Nabriva Therapeutics Plc 4
4 · Nabriva Therapeutics Plc · Filed Jul 5, 2017
Insider Transaction Report
Form 4
Crotty Robert
General Counsel & Corp Secreta
Transactions
- Award
Stock Option
2017-06-30+90,000→ 90,000 totalExp: 2027-06-30→ Ordinary Shares (90,000 underlying)
Footnotes (2)
- [F1]The exercise price is $10.48 per share.
- [F2]This option was granted on June 30, 2017. Vesting will begin on June 30, 2017 and end on June 30, 2021. Twenty-five percent (25%) of the option will vest on June 30, 2018, and the remaining seventy-five percent (75%) will vest on a monthly pro-rata basis over the remaining vesting period.